News
3d
Pharmaceutical Technology on MSNEchosens and Boehringer expand partnership for MASH diagnosisEchosens and Boehringer Ingelheim have expanded their collaboration aimed at expediting progress in metabolic ...
This expansion will change the trajectory of MASH by focusing on early detection, diagnosis, and access to care.
A novel canine-specific detection algorithm is designed to improve early identification of heart disease and expand access to ...
Targeting PDE4 drives anti-inflammatory and antifibrotic effects, and Boehringer has been working on its own PDE4 inhibitor ...
Biopharmaceutical company Boehringer Ingelheim is using data and more to drive organizational change and has outlined four ...
4d
Vietnam Investment Review on MSNEchosens and Boehringer Ingelheim deepen partnership for MASH careBy combining their diagnostic and therapeutic expertise, Echosens and Boehringer Ingelheim aim to help close persistent gaps ...
Boehringer Ingelheim & Eko Health ink digital health collaboration to improve heart murmur detection in dogs: Ingelheim, Germany Wednesday, June 11, 2025, 10:00 Hrs [IST] Boehring ...
Ingelheim: Boehringer Ingelheim and Eko Health have entered a strategic collaboration agreement to improve heart murmur ...
June 10, 2025 | Boehringer Ingelheim, a global leader in animal health, and Eko Health, a pioneer in applying artificial intelligence (AI) for early detection of heart and lung diseases ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results